Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector.
J Med Chem. 2024 Apr 11;67(7):5216-5232. doi: 10.1021/acs.jmedchem.3c01790. Epub 2024 Mar 25.
J Med Chem. 2024.
PMID: 38527911
Free PMC article.
The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo.
Merayo N, Rachid Z, Qiu Q, Brahimi F, Jean-Claude BJ.
Merayo N, et al.
Anticancer Drugs. 2006 Feb;17(2):165-71. doi: 10.1097/00001813-200602000-00007.
Anticancer Drugs. 2006.
PMID: 16428934
Item in Clipboard
The combi-targeting concept: in vitro and in vivo fragmentation of a stable combi-nitrosourea engineered to interact with the epidermal growth factor receptor while remaining DNA reactive.
Qiu Q, Domarkas J, Banerjee R, Merayo N, Brahimi F, McNamee JP, Gibbs BF, Jean-Claude BJ.
Qiu Q, et al. Among authors: merayo n.
Clin Cancer Res. 2007 Jan 1;13(1):331-40. doi: 10.1158/1078-0432.CCR-06-0812.
Clin Cancer Res. 2007.
PMID: 17200372
Item in Clipboard
Cite
Cite